Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹17 Cr₹28 Cr₹-7.31 Cr₹52 Cr₹48 Cr

What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of BALAXI PHARMACEUTICALS is ₹17 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹17 Cr
Mar2025₹28 Cr
Mar2024₹-7.31 Cr
Mar2023₹52 Cr
Mar2022₹48 Cr

How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹17 Cr
-37.33
Mar2025 ₹28 Cr
Positive
Mar2024 ₹-7.31 Cr
Negative
Mar2023 ₹52 Cr
7.39
Mar2022 ₹48 Cr -

Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹132.6 Cr -1.8% 1.4% -51% Stock Analytics
ADANI ENTERPRISES ₹409,501.0 Cr 2.1% -4.6% 21.7% Stock Analytics
AEGIS LOGISTICS ₹47,614.9 Cr 9.2% 4.6% 73.9% Stock Analytics
PREMIER ENERGIES ₹47,036.2 Cr 1% -1.7% -6.6% Stock Analytics
ADITYA INFOTECH ₹41,192.9 Cr -0.6% -5% NA Stock Analytics
REDINGTON ₹27,319.1 Cr 25% 26.5% 9.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.8%

1.4%

-51%

SENSEX

2.2%

0.9%

-3.7%


You may also like the below Video Courses